British Journal of Pharmacology. Dec 01, 2017 174 The Concise Guide to PHARMACOLOGY 2017/18. This issue was published by Wiley with financial contributions from the British Pharmacological Society, the International Union of Basic and Clinical Pharmacology and the University of Edinburgh, who host the guidetopharmacology.org website.S1:S1-S16
Wilcox, M H, Gerding, D N, Poxton, I R, Kelly, C, Nathan, R, Birch, T, Cornely, O A, Rahav, G, Bouza, E, Lee, C, Jenkin, G, Jensen, W, Kim, Y-S, Yoshida, J, Gabryelski, L, Pedley, A, Eves, K, Tipping, R, Guris, D, Kartsonis, N, Dorr, M-B, MODIFY I and MODIFY II Investigators & Glerup, H 2017, ' Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection ', The New England Journal of Medicine, vol. 376, no. 4, pp. 305-317 . https://doi.org/10.1056/NEJMoa1602615
McKinnell, JA; Bartsch, SM; Lee, BY; Huang, SS; & Miller, LG. (2015). Response to McKinnell et al's Original Article "Cost-Benefit Analysis From the Hospital Perspective of Universal Active Screening Followed by Contact Precautions for Methicillin-Resistant Staphylococcus aureus Carriers" Reply. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 36(7), 857-858. doi: 10.1017/ice.2015.112. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/5273q4w3